Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.

R Aggarwal, Neil; E Beaty, Laurel; D Bennett, Tellen; E Carlson, Nichole; B Davis, Christopher; M Kwan, Bethany; A Mayer, David; C Ong, Toan; Russell, Seth; Steele, Jeffrey; F Wogu, Adane; K Wynia, Matthew; D Zane, Richard; A Ginde, Adit

doi:10.1101/2022.04.03.22273360

Public

Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.

Shared by NobleBlocks on Apr 5, 2022 • 12:00 AM UTC

Authors:

Neil R Aggarwal

Laurel E Beaty

Tellen D Bennett

Abstract

Background: It is not known whether sotrovimab, a neutralizing monoclonal antibody (mAb) treatment authorized for early symptomatic COVID-19 patients, is effective against the SARS-CoV-2 Delta variant to prevent progression to severe disease and mortality. Methods: Observational cohort study of non-...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!